Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 3Resectable Pancreatic Cancer 1Pancreatic Ductal Adenocarcinoma 1Adenocarcinoma of the Pancreas 1Adenocarcinoma 1

Interventions

Gemcitabine 2130-nm albumin-bound paclitaxel 2paricalcitol 1mitazalimab 1ivosidenib 1Tissue Banks 1Specimen Handling 1Positron Emission Tomography Computed Tomography 1Parturition 1Oxaliplatin 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Losartan 1Leucovorin 1Irinotecan 1Hydroxychloroquine 1Glucose 1Genetic Testing 1Fluorouracil 1Fecal Microbiota Transplantation 1Escitalopram 1Contrast Media 1Capecitabine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Ductal Adenocarcinoma × paricalcitol × 1 year × Clear all
NCT05365893 2026-05-22

PHL Treatment in Pancreatic Cancer

Fox Chase Cancer Center

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡